ESR1 and breast cancer: This diagnostic study assesses the detection rates for distant metastases in patients with estrogen receptor (ER)–positive breast cancer and recurrences in patients with ER-positive breast cancer using 16α-18F-fluoro-17β-estradiol positron emission tomography (PET) compared with standard-of-care imaging.